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Background:  Limited data exist about clinical outcome of multiple chronic total occlusions (CTOs) according to therapeutic strategies; 
coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), optimal medical treatment (OMT). The aim of this study 
was to investigate the clinical outcome and the relative efficacy of three possible therapeutic strategies for patients with multiple CTOs (≥2 
CTOs).
methods:  From March 2003 to February 2012, total 2024 patients with at least one CTO were enrolled in a retrospective, single-center 
registry. 393 patients had at least two CTOs, they were categorized as intention to treat principle. The primary outcome was major adverse 
cardiac and cerebral event, including cardiac death, cerebrovascular accidents, acute myocardial infarction and repeat revascularization.
results:  The median follow up duration was 46.5 (interquartile range: 22.7 to 74.6 months) months. In 393 patients with multiple CTOs, 
169 patients (43%) referred for CABG, 130 (33%) for PCI, 94 (24%) for OMT. Of three therapeutic strategies in multiple CTOs, CABG had 
benefit in incidence of major adverse cardiac and cerebral event (MACCE), compared with PCI (11.2% vs 20.0%; p < 0.01) or OMT (11.2% 
vs 39.4%; p < 0.01). Incidence of repeat revascularization was significantly low in CABG, compared with PCI (0.6% vs 11.5%; p < 0.01) 
and OMT (11.2% vs 19.1%; p < 0.01). CABG had similar incidence of cardiac death, compared with PCI group (5.9% vs 6.9%; p = 0.49), 
but had significantly low incidence of cardiac death, compared with OMT (5.9% vs 19.1%; p < 0.01).
Conclusion:  For multiple CTOs management, compared with CABG, OMT alone was associated with a higher cardiac death and MACCE. 
PCI was also associated with a higher MACCE, as driven by a higher repeat revascularization although it has a comparable risk of cardiac 
death. These findings suggest that CABG might be considered as preferred treatment strategy in patients with multiple CTOs.
